title: Usefulness of epoprostenol therapy in the severely ill adolescent/adult with Eisenmenger physiology.
authors.affiliation: Boston Adult Congenital Heart Service, Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: Susan M
authors.initials: SM
authors.lastname: Fernandes
authors.forename: Jane W
authors.initials: JW
authors.lastname: Newburger
authors.forename: Peter
authors.initials: P
authors.lastname: Lang
authors.forename: Dorothy D
authors.initials: DD
authors.lastname: Pearson
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Feinstein
authors.forename: Kimberlee
authors.initials: K
authors.lastname: Gauvreau
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Landzberg
mesh_terms: D000293:Adolescent; D000328:Adult; D006328:Cardiac Catheterization; D016638:Critical Illness; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004541:Eisenmenger Complex / Q000175:diagnosis* / Q000188:drug therapy*; D004562:Electrocardiography; D011464:Epoprostenol / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006334:Heart Function Tests; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D012189:Retrospective Studies; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D011464:Epoprostenol